These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9742290)

  • 1. Lisuride acts at multiple sites to induce ocular hypotension and mydriasis.
    Potter DE; Ogidigben MJ; Chu TC
    Pharmacology; 1998 Nov; 57(5):249-60. PubMed ID: 9742290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action.
    Chu TC; Ogidigben MJ; Potter DE
    Exp Eye Res; 1999 Aug; 69(2):227-38. PubMed ID: 10433858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular actions of an octahydrobenzo[f]quinoline: Ha117.
    Potter DE; Ogidigben MJ; Heath AR
    Eur J Pharmacol; 1993 May; 236(1):61-8. PubMed ID: 8100528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors.
    Chu TC; Wong W; Gluchowski C; Hughes BW; Potter DE
    Curr Eye Res; 1996 Sep; 15(9):943-50. PubMed ID: 8921215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular actions of moxonidine: a possible role for imidazoline receptors.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1994 Jun; 269(3):897-904. PubMed ID: 7912282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxymetazoline: potential mechanisms of inhibitory effects on aqueous humor dynamics.
    Chu TC; Ogidigben MJ; Potter DE
    Pharmacology; 1996 Oct; 53(4):259-70. PubMed ID: 8958565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation.
    Moore TT; Potter DE
    Exp Eye Res; 2001 Aug; 73(2):167-78. PubMed ID: 11446767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evidence for heterogeneity of ocular alpha 2 adrenoceptors.
    Crosson CE; Heath AR; DeVries GW; Potter DE
    Curr Eye Res; 1992 Oct; 11(10):963-70. PubMed ID: 1360396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular inhibitory effects of the dopamine DA2 agonist (Ha-118) in cats and rabbits.
    Potter DE; Burke JA; Ogidigben MJ
    J Auton Pharmacol; 1990 Jun; 10(3):153-61. PubMed ID: 1974256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocine.
    Russell KR; Potter DE
    J Pharmacol Exp Ther; 2001 Sep; 298(3):941-6. PubMed ID: 11504788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cianergoline lowers intraocular pressure in rabbits and monkeys and inhibits contraction of the cat nictitans by suppressing sympathetic neuronal function.
    Potter DE; Shumate DJ
    J Ocul Pharmacol; 1987; 3(4):309-21. PubMed ID: 3503920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular hypotensive action of topical flunarizine in the rabbit: role of sigma 1 recognition sites.
    Campana G; Bucolo C; Murari G; Spampinato S
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1086-94. PubMed ID: 12438531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential sites of action of TNPA: a dopamine-2 receptor agonist.
    Chu E; Chu TC; Potter DE
    Exp Eye Res; 1999 Dec; 69(6):611-6. PubMed ID: 10620390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-2 adrenergic modulation of norepinephrine secretion in the perfused rabbit iris-ciliary body.
    Jumblatt JE; Liu JG; North GT
    Curr Eye Res; 1987 Jun; 6(6):767-77. PubMed ID: 3038473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular hypotensive effects of medetomidine and its analogs.
    Jin Y; Wilson S; Elko EE; Yorio T
    J Ocul Pharmacol; 1991; 7(4):285-96. PubMed ID: 1687323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration in ocular function induced by phenylethylamine analogs of dopamine.
    Potter DE; Burke JA; Chang FW
    Curr Eye Res; 1984 Jun; 3(6):851-9. PubMed ID: 6329603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: a dopamine(3) receptor agonist.
    Chu E; Chu TC; Potter DE
    J Pharmacol Exp Ther; 2000 Jun; 293(3):710-6. PubMed ID: 10869368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adrenomedullin on cyclic AMP formation and on relaxation in iris sphincter smooth muscle.
    Yousufzai SY; Ali N; Abdel-Latif AA
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3245-53. PubMed ID: 10586949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allicin-induced hypotension in rabbit eyes.
    Chu TC; Ogidigben M; Han JC; Potter DE
    J Ocul Pharmacol; 1993; 9(3):201-9. PubMed ID: 8228529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.